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including values in a range more closely mimicking those of the native ECM and (iii) minimal swelling of crosslinked gels.
Despite the continued interest in both grafted synthetic polypeptides, [6] [7] [8] [9] [10] [11] [12] and in step-growth PEG hydrogels formed from -functional and star macromers and even proteins, 13 the literature offers limited precedence for step-growth hydrogels in which a synthetic polypeptide acts as the primary polymer backbone in the network. Established polypeptide gels rely almost exclusively on crosslinking charged polypeptides from native amino acids such as poly(glutamic acid), 14, 15 poly(lysine), 16 and poly(aspartic acid), 17 with only recent work introducing nanogels crosslinked through photodimerization of polypeptide-side chain cinnamyloxy groups 18 or horseradish peroxidase mediated enzymatic crosslinking. 19 Hydrogels formed from neutral synthetic polypeptides have consisted almost exclusively of physical self-assembled gels, 6, 20, 21 rather than covalent crosslinking which is introduced here.
One specific N-carboxyanhydride polymerized polypeptide, poly(γ-propargyl L-glutamate) (PPLG), was previously established in the Hammond group 22 and forms the foundation of this work. As outlined in a recent review, 23 this polypeptide's pendant alkynes allow grafting of a wide variety of azide functionalized side chains via copper catalyzed 1,3-cyclo addition.
Examples of reported grafting groups include long PEG chains, 22 short sugar molecules, 24 amines, 25 sulfonate ions, 26 and thermoresponsive ethylene glycol grafting groups. 27 The geometry associated with the robust α-helix of the polypeptide both before and after grafting of the polypeptide allows for almost perfect grafting efficiency, largely insensitive to the properties of the side chains azide groups. 22 We demonstrated that step-growth hydrogels crosslinked through grafted α-helical polypeptides exhibit an increased elastic modulus compared to gels from polypeptides having random coil secondary structure. 28 Gel crosslinking was demonstrated 4 through anhydrous activation of ethylene oxide grafted PPLG by a non-specific coupling agent in organic solvent, and, without purification, crosslinking through 4-arm PEG-thiol (10K). 28 In this report, a new PPLG crosslinked hydrogel platform is developed by introducing a waterbased modular, biocompatible, macromer synthetic strategy allowing peptide modification and cell encapsulation. Two different crosslinking moieties are used to create systems that can be singly as well as doubly crosslinked in a subsequent step.
Specifically, a 4-arm PEG-thiol is crosslinked with PPLG macromonomers pre-grafted with a short PEG brush presenting a mixture of two orthogonal crosslinking chemistries: maleimides and norbornenes. Maleimides react extremely efficiently in a pH dependent addition reaction with thiols [29] [30] [31] while norbornenes react with thiols in UV activated thiol-ene reactions. 32 This design, which allows double crosslinking, builds on recent advances in fabricating cell culture systems engineered with temporal and spatial modulation of both mechanical properties [33] [34] [35] and bio-active grafted groups. 35, 36 Fabricating hydrogels from polypeptide macromers having orthogonal groups leverages the robust, efficient, and tractable PPLG grafting to enable synthetic controls of a wide range of well-characterized and highly versatile hydrogel systems. The strategies presented here for grafting norbornene and maleimide functionality onto PPLG can be readily extended to introduce a variety of crosslinking chemistries, 37, 38 crosslinker lengths, 39 and solubilizing brushes, creating a versatile system for biomolecular scaffolds and tunable 3D cellular environments. Finally, the modular synthesis of crosslinker-grafted PPLG polypeptides enables foundational theoretical and experimental characterization of how introducing polypeptide α-helical crosslinkers can direct bulk gel properties.
Materials and Methods
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L-(+)-Glutamic acid 99% minimum was purchased from EMD Chemicals (Gibbstown, NJ). Figure S5 . Gel characterization. All gels (i.e., PPLG-based and control PEG-only gels) were swollen in excess PBS overnight at 37°C.
Swelling and Polymer Incorporation. Gel were crosslinked as outlined above in the specific geometry of a 1 ml syringe from which the tip had been removed allowing gels to be plunged from the syringe. Gels made from 30 μL precursor solution (n=3) were equilibrated to room temperature and the swollen mass of each gel was measured. For each gel, the volumetric swelling ratio was estimated as the ratio of precursor volume to swollen gel mass. Gels were then placed on tared glass slides and dehydrated under vacuum for 24 hours. The mass swelling ratio is reported as the ratio of swollen mass to dry mass, each mass less the assumed mass of salt from PBS (10.7 mg/ml in liquid fraction).
AFM Mechanical Measurements. Gel were crosslinked as outlined above in the specific geometry of being sandwiched between two hydrophobic glass slides which had been treated (1 − )
Where F = applied force, R = radius of particle, δ = indentation depth, and v = Poisson's ratio, which was assumed to be 0.5 for all hydrogels. IGOR Pro data analysis software (WaveMetrics, Lake Oswego, OR) was used to analyze all force curves.
Cell culture and characterization hMSCs were maintained in a standard medium formulation containing Dulbecco's modified Eagle's medium, 10% fetal bovine serum (FBS), 1 mM pyruvate, 1 mM L-glutamine, 1μM nonessential amino acids, and 100 units/ml penicillinstreptomycin (Life Technologies, Grand Island, NY), at 37°C in a humidified atmosphere of 5% CO 2 / 95% air.
2D cell adhesion. PPLG 160 -g-(malemide x EO2 z ) or control 8-arm PEG mal precursor solutions were mixed with PEG-thiol as outlined above with addition of RGD, RGE and AG73 peptides at 0-750 μM final nominal concentration before swelling. For all gels, thiol terminal peptides were pre-incubated with maleimide grafted polymer and buffer for 30 minutes before PEG thiol to insure complete peptide incorporation as verified by Ellman's Assay. Gel precursor solution (10 μL) was added to wells of an Ibidi 96 well angiogenesis plate, (specialized wells that limited meniscus formation), swelled overnight in PBS, then incubated for 2 hours in undiluted serum media before being seeded with hMSCs in 50 μL media (1,750 cells per well, n=4 wells per condition, two complete biological replicates). After 6 hours cells were imaged in bright field in a humidified chamber before non-adherent cells were washed with PBS, and adherent cells were fixed and stained with DAPI, staining cell nuclei, and with rhodamine-phalloidin, staining fibrullar actin (Life Technologies, Grand Island, NY). Average adherent cell number and cell morphology were observed by fluorescence microscopy.
Results and Discussion
PPLG Macromer Synthesis.
PPLG was synthesized as reported 22 having a degree of polymerization of 160 as calculated by Grafted ratios of N 3 -PEG n=10 -maleimide and N 3 -PEG n=10 -norbornene, calculated through 1 H NMR closely match that of the feed ratios ( Figure S2 ). This robust, near-stoichiometric functionalization makes grafted-PPLG an especially attractive and versatile hydrogel macromer.
Further, this strategy of azide crosslinker synthesis eliminates challenges in maintaining crosslinker stability during intermediate purification, limits consumption of expensive discreet PEG linker, and allows modularity in both the length of PEG linker and the choice of the crosslinking group. With careful processing, final products were obtained with minimal background macromer crosslinking as characterized by GPC ( Figure S3 ). Future work might extend PPLG grafted crosslinkers to less reactive Michael-type acceptors than the unprotected 14 maleimides groups used here, which can spontaneously crosslink during purification when highly substituted. The robust character of the azide-alkyne grafting also offers significant synthetic flexibility to extend beyond the solubilizing EO2 chain along the backbone.
Step-growth stochastic crosslinking model predicts minimum PPLG grafted crosslinker functionality required for gel formation. Figure S4 ) and the relative molar ratios of the two reacting groups. Previous solution phase studies strongly support bionomial or stochastic grafting onto PPLG, 27 suggesting that PPLG-grafted maleimide weight average functionality, f w,A , be more accurately modeled assuming a binomial distribution of PPLG crosslinker grafting centered on the average crosslinker functionality observed by 1 H NMR (Figure 1b) . Figure 1c presents modeled gelation for experimental tested hydrogels crosslinked through PPLG 160 -gmaleimide macromers (crosslinker functionally =f avg and gel stoichiometric ratios of maleimide to thiol =r) as modeled by Flory Stockmayer theory assuming average or binomial PPLG crosslinker grafting.
Modeling the gel system with the simplifying assumption equating PPLG weight average functionality to NMR calculated average functionally closely matches observed gel behavior but slightly overestimates the minimum average of maleimides per PPLG required for gel formation (Figure 1c and Figure S4 ). However, applying Flory-Stockmayer theory assuming a binomial distribution of maleimide grafting groups perfectly supports experimental observations in 18 suggesting a minimum average of 1.3 maleimides per PPLG is required for gel formation corresponding to a stoiometric ratio of 0.24 maleimide per thiol (Figure 1c and Figure S4 ).
Together these results highlight the well-controlled character of hydrogels crosslinked through crosslinker-grafted PPLG and suggest the importance of integrating heterogeneous crosslinker functionally into modeling gels formed from grafted PPLG and similarly heterogeneous crosslinking systems.
Swelling of hydrogels crosslinked through PPLG 160 -g-(crosslinker x,y EO2 z )
The effect of the precursor crosslinking groups' stoichiometric ratio on the swelling behavior in PBS of PPLG grafted with crosslinkers and EO2 was investigated and compared to three control PEG hydrogel systems. As introduced above, precursor solutions of maleimide and EO2
grafted PPLG (4 wt%, 1.6-7.4mM maleimide) and 4-arm PEG-thiol (10K) (1. The pH of each precursor solution was adjusted between pH 5.2 and pH 7.4 to tune the time to gelation to between 2 and 30 minutes ( Figure S5 ). More acidic conditions decrease the reactivity of the thiol species and the overall crosslinking rate, allowing time for sufficient mixing of polymer precursor solutions containing PPLG with high maleimide grafting. Gels were soaked for around 16 hours in PBS, a buffer chosen for having physiologically relevant pH and salt concentration. Swelling time was selected to ensure gel equilibration without significant PPLG 20 backbone ester bond hydrolysis. 43 Gels were weighed and the volume swelling ratio, Q v , was calculated for each gel system, (Q v =swollen gel volume per precursor solution volume).
Polymer gels were then lyophilized and again weighed to quantify lost mass of unincorporated polymer material, where contributions of dried salts were corrected for assuming equal partitioning of PBS salts into the aqueous phase of the gel. The swelling ratio, q= swollen gel mass per dry polymer mass, was also calculated.
Gels made from PPLG grafted with more than on average 2. To form sequentially, orthogonally crosslinked gels, precursor solutions of PPLG-g-maleimide and norbornene (4 wt%) with 4-arm PEG-thiol (10K) (1.3 wt%) and 0.05wt % Irgacure were allowed to react at pH 5.2 for 45 minutes without UV, forming the first crosslink. Sequentially, orthogonally crosslinked gels resulted from exposing maleimide-crosslinked gels to UV at 10 mwatts/cm 2 for 5 minutes, crosslinking the norbornene groups in orthogonal fashion. All gels were swollen overnight in PBS. The swelling behaviors of sequentially, orthogonally crosslinked gels were compared to those of gels subjected to the first step only, i.e, to gels crosslinked only through maleimide groups. Swelling behavior and polymer retention was insensitive to the number of crosslinking steps in gels where the molar ratios of maleimides to thiols in the first (or only) step was r=0.53 or 0.77. However, when the ratio of maleimides to thiols was further reduced, to r = 0.24, PPLG 160 -g-(mal 1.3 nor 8 EO2 151 ) formed a gel after the first crosslinking step, but the resulting gels had the highest volumetric swelling ratio and swelling volume of all PPLG 21 crosslinked gels (Figure 2c ) and only retained 70% of the crosslinking polymer after swelling.
The 30% polymer mass loss observed for PPLG 160 -g-(mal 1.3 nor 8 EO2 151 ) crosslinked just through maleimides (i.e., first step only) was attributed to both non-crosslinking of an estimated 27% of the PPLG macromers expected with stochastic grafting to have zero grafting groups ( Figure 1b) and to gel network defects caused by incomplete crosslinking of PPLG macromers with only 1 or 2 grafted maleimides. The polymer loss and greater swelling of this loosely crosslinked gel resulted in its high swelling ratio (q) of 25; whereas all other PPLG gels tested had greater than 90% precursor polymer retention after swelling and q ranging from 13 to 20. A subsequent crosslinking step through the norbonene groups (r = 2.0) rescued the properties, resulting in gels with comparable swelling and mass properties to the gels with r >0.5 at the first maleimide step (Figure 2c ).
Three series of control gels having precursor solutions of 4-arm PEG-thiol (10K) and 8-arm PEG-mal (10K) or (40K) were also crosslinked (Figure 2b ). Gel precursors having equimolar thiol and maleimide functional groups were selected to match PPLG 160 -g-(mal x EO2 z ) gels in either total wt% polymer or molarity of thiol. Specifically, PEG Control A (1.8 wt% 8-arm PEGmal (10K) and 3.5 wt% 4-arm PEG-thiol (10k)) and PEG Control B (3.4 wt% 8-arm PEG-mal (40K) and 1.9 wt% 4-arm PEG-thiol (10K)) both contained 5.3 wt% polymer. PEG control C (2.3 wt% 8-arm PEG-mal (40K) and 1.3 wt% 4-arm PEG-thiol (10K)) matched grafted-PPLG gel crosslinker molarity but was only 3.6 wt% polymer. From each base polymer system, a series of control gels having stoichiometric ratios less than 1 were generated by reacting 8-arm PEGmaleimide macromers with varied ratios of 2-mercaptoethanol prior to crosslinking, effectively capping or removing crosslinking maleimides while preserving constant precursor polymer wt%.
In all three gel systems, decreasing crosslinking by increasing maleimide capping increased swollen gel volume and volumetric swelling ratio (Figure 2c ).
Comparing the swelling behavior of control PEG gels to PPLG gels demonstrates how the distinct nanostructure of each macromer influences bulk gel properties. Swelling of all three PEG gel systems greatly increased with decreased maleimide crosslinking functionality (decreased r).
PEG hydrogels increased their swelling from 50% to 2 to 3 times their precursor volume when the crosslink density is varied from the maximum density (i.e. r = 1.0, crosslink density of 4.4 mM) to the lowest crosslink density examined (i.e., r =0.6, crosslink density of 2.6 mM), as shown in Figure 2c . Such swelling dependence on crosslinking density has been demonstrated in published PEG systems 44 and is well-supported by classic elastic polymer crosslinking theory governing the crosslinking of Gaussian chains. In contrast, gels crosslinked through PPLGgrafted maleimides showed relatively consistent volumetric swelling, comparatively insensitive to gel crosslinker concentration. Moreover even at maleimide concentrations approaching the minimum required for gel formation, gels crosslinked through PPLG-grafted maleimide did not swell beyond their precursor volume (Figure 2c ).
This unusual near-neutral swelling behavior of gels crosslinked through PPLG macromers can likely be attributed to preservation of the α-helical secondary structure of the polypeptide backbone throughout the crosslinking process. The robust α-helical stability of grafted PPLG has been well-established through solution phase studies 22, 27, 43 and strongly suggested in gels. 28 The ordered polypeptide chain conformation leads to a lower entropic force driving gel swelling than in PEG-only gel systems. The contribution of the grafted α-helical polypeptides to bulk gel properties is especially significant in this particular gel system as PPLG 160 -g-(mal x EO2 z ) accounts for 75% of the total polymer mass and in a space filling model, 21% of the total crosslinking volume of an unswollen grafted PPLG gel ( Figure S6 ).The low to neutral swelling properties exhibited in these gels, especially as a function of crosslinking, is particularly noteworthy considering the more typical swelling demonstrated even by most protein crosslinked gels 45 and the limited development and high potential for low swelling gels is of great interest, especially for biomedical applications.
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Mechanical properties of hydrogels crosslinked through PPLG 160 -g-(crosslinker x,y EO2 z )
Elastic moduli measurements characterizing the series of swollen PPLG 160 -g-(mal x EO2 z ) gels
show gel stiffnesses increasing from 3 kPa to 17 kPa for gels crosslinked with stoichiometric ratios of 0.36 to 1.68, corresponding to 1.9 to 9.8 grafted maleimides per PPLG (Figure 3a) . Of particular note, PPLG 160 -g-(mal 5.6 EO2 154 ) (r= 1.01) and PPLG 160 -g-(mal 9.8. EO2 150 ) (r= 1.68) both have bulk maleimide concentrations sufficient to allow complete PEG thiol consumption and maximum gel crosslinking, suggesting that gels crosslinked through these macromers should have similar bulk properties. The increase in stiffness from 9 kPa to 17 kPa for gels crosslinked with excess maleimides, suggesting a different topology for the two crosslinked gels. This difference is primarily attributed to the steric challenges crosslinking of rigid macromers having non uniform distribution of crosslinker functionality ( Figure S7 ) with potential additional contributions through limited pre-gelation homo-crosslinking of PPLG chains with high maleimide substitution ( Figure S3 ). PEG-only control gels had moduli ranging from 9 kPa to 16 kPa ( Figure S8 ). crosslinking strategies to allow temporal and spatial control of gel mechanical properties. 33, 48 In addition to reacting with thiol groups as demonstrated here, pendent norbornene groups might also react with tetrazine-functionalized crosslinkers 49, 50 or biocues.
51
Cell attachment to RGD-modified hydrogels crosslinked through PPLG 160 -g-(mal x EO2 z )
PPLG-crosslinked hydrogels were further characterized by quantifying hMSC attachment to a series of PPLG gels modified with an RGD motif in comparison to similarly functionalized control PEG-only gels. Demonstrating how cell attachment to PPLG-crosslinked gels depends on ligand density and gel mechanical properties establishes the potential utility of polypeptide crosslinked step-growth hydrogels as a platform for synthetic extracellular matrices and extends previous studies demonstrating the biocompatibility and stability of PPLG in drug delivery 52 and self-assembled gels 21 applications. Additionally, as hMSCs are well-known to attach and spread only on 2D hydrogels that are both sufficiently stiff and adhesive, 53, 54 cell attachment behaviors offer crucial insights into whether the enhancements in mechanical properties and ligand densities afforded by the new macromer translate into enhancements in cell function compared to standard PEG gels .
Systematically varied stoichiometric ratios of an integrin-binding RGD motif (see Methods) or control peptide (RGE) were grafted to PPLG macromers via reaction with thiols prior to crosslinking, as hMSC are known to attach to RGD-containing substrates. 53, 54 In some experiments, a peptide that has been reported to bind to heparine was added to the RGD motif (see Methods). 55 Fluorescein-labeled RGD was additionally substituted at 2% of the total RGD in some gels to monitor macroscale gel homogeneity and verify peptide incorporation. Gels crosslinked through PPLG 160 -g-(mal 1.9 EO2 158 ), PPLG 160 -g-(mal 2.2 EO2 158 ), or PPLG 160 -g-(mal 9.8 EO2 150 ) were selected as representative of soft, medium or hard PPLG-grafted gels, as The effects of RGD peptide incorporation on cell attachment were assessed by creating a panel of gels in which the nominal RGD concentrations present in the crosslinking solution were varied systematically such that the actual (post-swelling) RGD ligand concentrations for PPLGcontaining and standard PEG gels would span a comparable range. The swelling data presented in Figure 2 were used to correct the nominal ligand concentrations to obtain estimated actual ligand concentrations experienced by cells during attachment. The relatively low fraction of thiol-terminated peptides added to the gels relative to crosslinking maleimides supports this swelling approximation (e.g. for all PEG gel precursor solutions less than 17% of crosslinking maleimides were consumed to support peptide incorporation). However, especially at high concentrations the specific nature of the capping molecule is known to influence hydrogel swelling requiring that swelling be explicitly measured for each gel formation. 57 At the relatively low ligand concentrations analyzed here (0-750 uM), PPLG-containing gels were generally more effective in fostering cell attachment than standard PEG gels with comparable ligand concentrations and stiffness (Figure 4a ). Cell attachment to standard PEG gels never exceeded more than about 30% of cell attachment to control tissue culture plastic, even at the highest RGD ligand concentration, ~700 uM (Figure 4a ), although robust attachment could be rescued by adding 20 uM AG73, a heparin binding peptide known to enhance integrin mediated adhesion in other synthetic extracellular matrixes ( Figure S9 ). 58, 59 In contrast, cell attachment to PPLG-containing RGD functionalized gels approached that on tissue culture polystyrene (70-80% for the 6 and 17 kPa gels) at an RGD ligand concentration of ~600 uM (Figure 4a ). Further, cell attachment to the 6 and 17 kPa PPLG-containing hydrogels at relatively low ligand concentration (~290 uM) was comparable to or exceeded the attachment observed for the ~700 uM RGD concentration in standard PEG gels (Figure 4a ). The very soft (3 kPa) PPLG gel could only be tested at relatively low ligand concentrations, due to exhaustion of the reactive groups during crosslinking, and it performed in a manner comparable to stiffer standard PEG gels (Figure 4a ).
Not surprisingly, for comparable ligand concentrations, cell attachment was moderately enhanced on stiffer gels for both PPLG and standard PEG (Figure 4a ), as has been previously reported for hMSCs interacting with PEG-based gels. 53, 54 Further, the relatively modest cell attachment to the softest PPLG-containing gels was consistent with morphological observations of cells on PPLG gels at these relatively low ligand concentrations (Figure 4b ). Although we did not quantify cell spread area, we observed that when cells were fixed and stained with phalloidin after 8 hr, virtually all cells on the soft gel had the characteristic rounded morphology illustrated in Figure 4b1 , whereas cells on the stiffer PPLG-containing gel and a representative PEG control gel were most frequently spread as illustrated in Figure 4b2 nano-scale organization or rigidity. As native extracellular matrices are engineered at the nanoscale through crosslinked proteins having defined secondary structure, crosslinking hydrogels through grafted PPLG offers the intriguing opportunity to introduce more complete control of both bulk and local gel architecture.
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Together, these 2D adhesion studies support cell-free gel characterization and suggest significant opportunity for grafted polypeptides to extend traditional PEG-only hydrogels.
Stepgrowth gels crosslinked through grafted PPLG largely maintain the baseline protein resistant character of PEG-only hydrogels while supporting the incorporation of additional chemical and biological functional though a more protein-like scaffold than conventional PEG hydrogels.
Future in vivo and in vitro 3D culture system for long term culture might also benefit from engineering an enzymatically degradable PPLG backbone to support cell remodeling or incorporating more hydrolytically stable related grafted polypeptides. 12,43 Conclusions
Step-growth hydrogels crosslinked through grafted PPLG is a promising platform for extending the potential of PEG-only hydrogels, especially for applications in tissue engineering.
Foundational characterization presented in this work demonstrates a modular, well-controlled synthetic platform for synthesizing crosslinker-grafted PPLG, which can be easily extended to a wide variety of covalent crosslinking chemistries. Characterization of gels crosslinked through grafted PPLG supports robust control of bulk hydrogel properties through systematically modulating the grafted polypeptide's functionality. Further, swelling ratios, polymer incorporation, and bulk gel stiffness measurements strongly support both stochastic substitution of PPLG grafting groups and significant retention of α-helical secondary structure of grafted-PPLG. Preliminary studies identify grafted PPLG as supporting 2D culture of immortalized mesenchymal stem cells and suggest utility of these hydrogels for systematically exploring the effect of defined secondary structure on local cell response and bulk hydrogel properties. The synthetic platform and theoretical framework developed here for PPLG-crosslinked gels might be readily expanded to direct design of other grafted polypeptide hydrogels with complementary grafting strategies.
Step-growth hydrogels crosslinked through engineered polypeptide 31 macromers having defined secondary structure and presenting a wide variety of crosslinking and biological functionality are expected to extend the level of cellular control and clinical utility achieved through existing engineered hydrogel systems. 
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